Edition:
United Kingdom

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

2.42USD
9:00pm BST
Change (% chg)

$0.06 (+2.54%)
Prev Close
$2.36
Open
$2.36
Day's High
$2.42
Day's Low
$2.35
Volume
3,415
Avg. Vol
27,426
52-wk High
$5.55
52-wk Low
$1.75

Chart for

About

OncoMed Pharmaceuticals, Inc. (OncoMed) is a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing therapeutics that address the fundamental biology driving cancer's growth, resistance, recurrence and metastasis. The Company's therapeutic candidates and preclinical programs include... (more)

Overall

Beta: 2.74
Market Cap(Mil.): $164.07
Shares Outstanding(Mil.): 37.63
Dividend: --
Yield (%): --

Financials

  OMED.OQ Industry Sector
P/E (TTM): -- 85.36 32.76
EPS (TTM): -2.38 -- --
ROI: -75.79 2.21 14.61
ROE: -- 3.85 16.34

BRIEF-Oncomed Reports Q1 Loss Per Share $0.15

* ONCOMED ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

08 May 2018

BRIEF-OncoMed Announces Appointment Of John Lewicki As CEO

* ONCOMED ANNOUNCES APPOINTMENT OF JOHN LEWICKI, PHD, AS PRESIDENT, CHIEF EXECUTIVE OFFICER AND A MEMBER OF THE BOARD OF DIRECTORS

19 Mar 2018

BRIEF-Oncomed Pharmaceuticals Reports Q4 Earnings Per Share $0.25

* ONCOMED PHARMACEUTICALS - CURRENT CASH IS ESTIMATED TO BE SUFFICIENT TO FUND OPERATIONS THROUGH AT LEAST Q3 OF 2019

08 Mar 2018

BRIEF-OncoMed Q4 Earnings Per Share $0.25

* ONCOMED ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

08 Mar 2018

Competitors

  Price Chg
Amgen, Inc. (AMGN.OQ) $192.80 -1.12
Astellas Pharma Inc (4503.T) ¥1,816 --
AstraZeneca plc (AZN.L) 5,606.00 +55.00
Bayer AG (BAYGn.DE) €92.96 -0.45
Bayer AG (BAYE.F) -- --
Celgene Corporation (CELG.OQ) $85.78 -0.07
Roche Holding Ltd. (ROG.S) CHF234.75 +2.75
Roche Holding Ltd. (RO.S) CHF238.80 +2.00
GlaxoSmithKline plc (GSK.L) 1,563.80 +2.80
Johnson & Johnson (JNJ.N) $127.80 -1.31

Earnings vs. Estimates